Molecular Biology of Prostate Cancer

Cytogenetic alterations in prostate cancer
The regulation of prostatic growth
Current concepts of oncogenes in prostate cancer
Tumour suppressor genes in prostate cancer
The use of differential display PCR for the detection of new tumor suppressor genes in prostate cancer
Molecular alterations associated with prostate cancer development
Dysfunction of the cell-cell adhesion complex in lethal prostate cancer
Heparan sulfate proteoglycans and prostate cancer: a conceptual framework
Androgen receptor mutations in prostate cancer
Antiandrogen binding to androgen receptors and the consequences
Expression of the MDR1 gene in prostate carcinoma
Human prostate cancer progression models and therapeutic intervention
Tumor angiogenesis: the VEGF signalling system is a novel target for prostate cancer therapy
Antimetastatic approaches to therapy of prostate cancer
Intermittent androgen supression: rationale and clinical experience
Resistance to drug therapy in cancer: gene therapy approaches to overcome anticancer drug resistance
PSA RT-PCR: current status and future potential
Special aspects of PSMA and PSA RT-PCR for the detection of disseminated prostate cells
Molecular forms of PSA, PSA density, age-/race-specific reference ranges, and PSA velocity
Reverse transcriptase-polymerase chain reaction assays used for molecular staging of prostate cancer patients
Concluding remarks